Currently the most modern M6 Cyberknife unit is in service since four years. Medical experience based on over 7000 treated patients since 2005. Wordwide.
Learn more about the Cyberknife centre »
Meet our team
With the Cyberknife therapy tumors are well treatable if indication criteria for the radiosurgery are fulfilled.
View the treatment advantages
Ronald H., 72
Here patients share their very personal experience with the Cyberknife therapy.
View testimonials »
Johannes W, 52
Useful information and interesting facts about Cyberknife in media and science.
You are welcome to send us your patient information to have them reviewed confidentially by our Cyberknife experts
Report your concerns
[Translate to Englisch:] Anfahrt & Wegbeschreibung »
A Cyberknife and a robotic arm holding an ultrasound probe can cooperate efficiently to guide prostate treatments.
Meta-analysis demonstrates efficacy and safety of Cyberknife treatment for primary renal cell carcinoma.
Orbital meningiomas benefit from combining surgery and early postoperative Cyberknife treatment.
In preparation of robotic ultrasound guidance for Cyberknife prostate treatments, robot setup was optimized.
International Radiosurgery Oncology Consortium for Kidney" (IROCK): Even in patients with a solitary kidney, renal function is maintained after...
After whole brain radiotherapy, Cyberknife remains a useful treatment option for recurrent brain metastases.
Monte Carlo dose calculation expands the treatment options for Cyberknife with MLC.
Renal cell carcinoma patients with a low number of bone metastases should be treated with curative intent, e.g. by radiosurgery.
The second publication from the "SPINO" expert group summarizes additional insights on radiosurgery of spinal metastases.
The international expert group "SPINO" provides new guidelines for outcome reporting in spinal radiosurgery.
"International Radiosurgery Oncology Consortium for Kidney" (IROCK): Radiosurgery for primary renal cell carcinoma is effective and well tolerated.
Functional outcome of AVM therapy is investigated in a randomized trial.
Call me back
Your direct contact to Cyberknife
+49 89 45 23 36 -0
Please send me the login credentials for the data upload.
European Cyberknife Center Munich Max Lebsche Platz 31 D - 81377 Munich, Germany
Phone: +49-89-452336-0Fax: +49-89-452336-16
Our office is open daily:
Monday - Friday: 7.30 - 8.00 pm (CET)Saturday and Sunday 9.00 - 6.00 pm (CET)
European Cyberknife Center MunichMax Lebsche Platz 31 D - 81377 Munich, Germany
Diese Website verwendet Cookies. Sie können der Verwendung von Cookies widersprechen.